PFIZER LTD. - 500680 - Shareholding for the Period Ended December 31, 2020
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here12-01-2021
12-01-2021
PFIZER LTD. - 500680 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 037370 Name of the Signatory :- PRAJEET NAIRDesignation :- Company Secretary and Compliance Officer12-01-2021
PFIZER LTD. - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated January 9, 2021, issued by KFin Technologies Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2020. We request you to take the same on record.12-01-2021
Pfizer says engaging with government', compiling answers to DCGI queries on vaccine: Report
Pfizer failed to present before the Subject Expert Committee (SEC) on vaccines in India on three occasions12-01-2021
UK will have offered 15 million COVID shots by mid-February, says minister
Having become the first country to approve vaccines developed by Pfizer-BioNTech and by Oxford-AstraZeneca, Britain will open seven large-scale vaccination centres as part of a plan for a mass rollout of COVID-19 shots.11-01-2021
Pfizer, Moderna vaccines may vanquish Covid today, cancer tomorrow
Ordinary vaccines tend to be inactivated or weakened viruses which, when injected into the body, stimulate an immune response that can later protect against the live pathogen09-01-2021
European Union doubles COVID-19 vaccines order with Pfizer-BioNTech
Speaking during a news conference in Brussels on Friday, European Commission president Ursula von der Leyen said the agreement will double the amount of doses already ordered by the 27-nation bloc08-01-2021
1 in 1,00,000 may have severe allergic reactions to Pfizer's Covid vaccine
US health officials stress that benefits of immunisation outweigh risks07-01-2021
India Coronavirus Dispatch: Lockdowns ravage Goa tourism economy
Experts assure safety of Pfizer and Moderna vaccines, documents needed for Co-Win app, research on Neanderthal gene, and more-news relevant to India's fight against Covid-1906-01-2021
BioNTech warns against delaying second vaccine dose
BioNTech, which developed the vaccine with US giant Pfizer, said its clinical data showing 95 percent efficacy was based on a two-dose schedule separated by 21 days.05-01-2021